HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Home treatment with Elaprase and Naglazyme is safe in patients with mucopolysaccharidoses types II and VI, respectively.

Abstract
Enzyme replacement therapy for lysosomal storage disorders has made an important contribution to improving the quality of life of affected patients. The treatment, however, is invasive and onerous, involving weekly or biweekly intravenous infusions of product over a 3-4 h period. Such therapy can be extremely disruptive of normal family life and the provision of a safe, home treatment regimen is greatly appreciated by affected families. In this report we demonstrate the safety of home treatment with Elaprase for mucopolysaccharidosis type II (17 patients) and Naglazyme for mucopolysaccharidosis type VI (6 patients). Careful patient selection, an experienced home care company and a detailed management plan for potential anaphylaxis and infusion-associated reactions are important components in a successful home treatment programme.
AuthorsS Bagewadi, J Roberts, J Mercer, S Jones, J Stephenson, J E Wraith
JournalJournal of inherited metabolic disease (J Inherit Metab Dis) Vol. 31 Issue 6 Pg. 733-7 (Dec 2008) ISSN: 1573-2665 [Electronic] United States
PMID18923918 (Publication Type: Journal Article)
Chemical References
  • Recombinant Proteins
  • N-Acetylgalactosamine-4-Sulfatase
  • galsulfase
  • Iduronate Sulfatase
  • idursulfase
Topics
  • Adolescent
  • Anaphylaxis (prevention & control)
  • Child
  • Child, Preschool
  • Home Care Services
  • Home Infusion Therapy (adverse effects, methods)
  • Home Nursing
  • Humans
  • Iduronate Sulfatase (administration & dosage)
  • Mucopolysaccharidosis II (drug therapy)
  • Mucopolysaccharidosis VI (drug therapy)
  • N-Acetylgalactosamine-4-Sulfatase (administration & dosage)
  • Recombinant Proteins (administration & dosage)
  • Time Factors
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: